Herz

Papers
(The TQCC of Herz is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Light at the end of the tunnel?45
Neue Optionen zur Intensivierung der lipidsenkenden Therapie31
Early echocardiographic evaluation of right ventricular load adaptability after sequential combination treatment in pulmonary arterial hypertension28
Timing of RAS blocker administration and long-term cardiovascular outcomes in STEMI patients21
Lebenslanges Lernen in der Kardiologie: Durch Innovation erfolgreich14
Management of the COVID-19 pandemic in Rhineland-Palatinate hospitals of all levels of care14
Survey of clinical practice pattern in Germany’s certified chest pain units13
Das Heart-Team: überbetonter Nutzen oder zwingend notwendig?11
Evaluation of the acute effects of inhaled iloprost on aortic compliance in pulmonary arterial hypertension using invasive methods11
Outcome of edge-to-edge vs. surgical repair in patients with functional mitral regurgitation and reduced left ventricular function9
Präzisionsmedizin bei Diagnostik und Therapie von Kardiomyopathien9
Rhythmusstörungen7
Predictive strength of inflammatory scores for in-hospital mortality in infective endocarditis7
Rolle der Genetik in der Präzisionsmedizin der koronaren Herzkrankheit6
Infarktbedingter kardiogener Schock6
The new ESC acute coronary syndrome guideline and its impact in the CPU and emergency department setting6
Precision medicine in the management of cardiac arrhythmias6
Cannabinoids and the heart—a psychiatrist’s perspective6
Cardiac amyloidosis—interdisciplinary approach to diagnosis and therapy6
Cardiac, possible cardiac, and likely non-cardiac origin of chest pain6
2022 ESC/ERS-Leitlinien zur Diagnostik und Therapie der pulmonalen Hypertonie6
ESC-Leitlinie 2022 zum kardiovaskulären Assessment und Management von Patienten, die sich einer nichtkardiologischen Operation unterziehen5
Is lysosomal acid lipase activity associated with the presence and severity of coronary artery disease?5
Long-term outcomes following double kissing crush or mini-culotte stenting for complex coronary bifurcation lesions: the EVOLUTE-CRUSH IV study5
eCardiology5
Therapie mit kardialen elektronischen implantierbaren Devices5
A mix of aminophylline and heparin plus nitroglycerin can reduce bradycardia during rotational atherectomy on the right coronary artery and dominant circumflex artery5
Koronare CT-Angiographie und koronare Atherosklerose5
Cardiovascular evaluation of pregnant women with hypertrophic cardiomyopathy5
Correlation between decreased plasma miR-29a and vascular endothelial injury induced by hyperlipidemia5
Increased cardiovascular risk in patients with chronic kidney disease5
Erratum zu: ESC-Leitlinien 2023 zum Management der Endokarditis5
Neue Aspekte implantierbarer elektrischer kardialer Geräte5
Diagnostik und Therapie der Lungenembolie4
Prognostic value of pulmonary artery diameter/aorta diameter ratio in patients with acute pulmonary embolism4
Epicardial adipose tissue as a prognostic marker in acute pulmonary embolism4
Safety and feasibility of same-day discharge following catheter ablation of atrial fibrillation: what is known and what needs to be explored?4
Impact of residual coronary artery disease on left ventricular function after percutaneous coronary intervention: a two-dimensional strain echocardiography study4
Precision medicine in the management of valvular heart disease4
Real-world evidence for the use of subcutaneous implantable cardioverter–defibrillators in China: A single-center experience4
Mind and body interventions in cardiology4
Environmental and climate cardiology: some environmental issues highlighted at the annual meetings of the German Society for Cardiology (DGK) from 2007 to 20234
Lipidsenkung: neue Substanzen und neue Konzepte4
Nutzen der kardialen Magnetresonanzdiagnostik für Patienten mit Herzrhythmusstörungen3
Prävention des plötzlichen Herztods3
Guideline-endorsed follow-up after percutaneous valve therapies—non-attendance of TAVI and MitraClip patients3
Interventionelle Therapie der Herzinsuffizienz3
On the gap between objective and perceived risks of COVID-193
Leitlinien 2021 – im Rückblick der Blick voraus?3
Cardiorenal benefits of mineralocorticoid antagonists in CKD and type 2 diabetes3
Luftverschmutzung, Lärm und Hypertonie3
ESC-Leitlinien 2021 zur Schrittmacher- und Resynchronisationstherapie3
Management des akuten Koronarsyndroms3
Erratum to: Right ventricular failure in pulmonary hypertension: recent insights from experimental models3
Has COVID-19 changed the spectrum of arrhythmias and the incidence of sudden cardiac death?3
Update Kardioonkologie3
Erratum zu: Gesättigte Fettsäuren und kardiovaskuläres Risiko: Ist eine Revision der Ernährungsempfehlungen angezeigt?3
Protecting healthcare personnel and patients over 3 years of COVID-193
Brustschmerz und kardiovaskuläre Erkrankungen bei Frauen3
Akute Herzinsuffizienz und kardiogener Schock3
Pulmonale Hypertonie bei Lungenerkrankungen3
Herz und Diabetes3
Update zur Behandlung der Aortenklappenstenose bei symptomatischen und asymptomatischen Patienten3
ESC-Leitlinie 2022 onkologische Kardiologie2
New categorization of chest pain: noncardiac is in, atypical is out!2
Sterblichkeit bei Patienten mit ST-Strecken-Hebungs-Myokardinfarkt in Deutschland2
Erratum to: Outcomes of patients with ST-segment myocardial infarction admitted during the COVID-19 pandemic2
Prognosticating short-term outcomes in patients with STEMI-ACS and intra-procedural slow-flow/no-reflow phenomenon2
Was ist neu im Management der peripheren arteriellen Verschlusskrankheit und der aortalen Erkrankungen?2
Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directions2
Morphologische und funktionelle Diagnostik der koronaren Herzkrankheit mittels Computertomographie2
Kalzifizierte Stenosen richtig behandeln2
Association between lipoprotein(a) and cardiovascular disease in patients undergoing coronary angiography2
Das Heart-Team bei koronarer Herzkrankheit: Sicht von Zentren mit institutionalisierter Herzchirurgie2
RAAS inhibition and beyond—cardiovascular medications in patients at risk of or affected by COVID-192
Healthcare provision of transcatheter aortic valve implantation in Germany2
A practical approach for the treatment of post-COVID symptoms2
Tetrandrine has protective role in myocardial ischemia/reperfusion injury via the TRPV2/Ca2+/calcineurin/NFAT axis2
Non-transvenous ICD therapy: current status and beyond2
Statinintoleranz und statinassoziierte Muskelschmerzen2
Chronic thromboembolic pulmonary hypertension—medical, interventional, and surgical therapy2
Zukunft der interventionellen Kardiologie2
Hauptstammintervention – Ist ein Stent doch besser als zwei?2
Role of the coronary sinus in risk stratification and prognostic evaluation of idiopathic pulmonary arterial hypertension2
The effect of high-power short-duration pulmonary vein isolation on PWPT—a predictor of paroxysmal atrial fibrillation2
Acute prevention of a heart attack2
0.072273969650269